Premier Biosoft said this week that it has bought ProteoIQ, a proteomic data-analysis software suite, from Australian bioseparations company NuSep for an undisclosed sum.
NEW YORK (GenomeWeb News) – Premier Biosoft said on Monday it has completed the acquisition of NuSep's software business ProteoIQ for an undisclosed amount.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Australian bioseparations firm NuSep said on Monday it has extended the closing date of its current share purchase offer to Aug. 26.
The company will use funds from the offering to market its products, invest in a Singapore plasma project, and for general corporate purposes.
The suit, which also names Pierce Biotechnology and Expedeon as defendants, alleges they infringe on a patent related to a cassette for use in electrophoretic gels.
Agilent, Bruker, Biocius, IonSense, NuSep, New England Peptide
The separations products company plans to buy the mass spec analysis software maker for at least $3 million.
The deal, valued at more than $3 million, would provide NuSep with BioInquire's ProteoIQ software, which helps customers identify proteins separated by mass spec instruments.
The Associated Press reports that gene-edited food may soon be for sale.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.
In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.